Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l’humeur et de l’anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes
Summary & key facts
The CANMAT 2023 update gives doctors clear, up-to-date advice for treating adults with major depressive disorder. It puts evidence into a practical, clinician-friendly format. The update says treatment should be a team effort between patients and clinicians, be tailored to each person, and follow a planned, systematic process with regular follow-up. The aim is to improve outcomes for adults living with depression.
- This is an updated set of clinical guidelines for managing major depressive disorder in adults.
- The recommendations are evidence-informed, meaning they are based on research and clinical evidence available to the guideline group.
- The guidelines are written to be clinician-friendly so doctors and other care providers can use them in everyday practice.
- A central focus of the update is collaborative care, which means patients and clinicians work together on treatment decisions.
- The update emphasizes personalized treatment plans, so care is adjusted to each person’s situation and needs.
- The guidelines recommend using a systematic approach, with planned follow-up and adjustments, to try to improve treatment results for adults with depression.
Abstract
The CANMAT 2023 updated guidelines provide evidence-informed recommendations for the management of MDD, in a clinician-friendly format. These updated guidelines emphasize a collaborative, personalized, and systematic management approach that will help optimize outcomes for adults with MDD.